|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.35 TWD | -0.67% |
|
-1.11% | -15.50% |
| May. 08 | EPS Bio Technology Corp. Approves Dividend for the Year 2023 | CI |
| Mar. 20 | EPS Bio Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Bio Technology Corp. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 470.17 million compared to TWD 463.45 million a year ago.
Net income was TWD 20.99 million compared to TWD 25.36 million a year ago. Basic earnings per share from continuing operations was TWD 0.88 compared to TWD 1.07 a year ago. Diluted earnings per share from continuing operations was TWD 0.88 compared to TWD 1.06 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.50% | 16.64M | |
| -6.41% | 12.2B | |
| -4.07% | 8.22B | |
| +5.77% | 5.72B | |
| +28.13% | 5.42B | |
| -59.44% | 2.7B | |
| +8.04% | 2.63B | |
| -6.47% | 2.38B | |
| +21.84% | 2.1B | |
| -8.15% | 1.81B |
EPS BIO TECHNOLOGY CORP. 
